PBU The Pension Fund of Early Childhood & Youth Educators Makes New Investment in Colgate-Palmolive Company $CL

PBU The Pension Fund of Early Childhood & Youth Educators purchased a new position in shares of Colgate-Palmolive Company (NYSE:CL) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 131,728 shares of the company’s stock, valued at approximately $10,409,000.

Other institutional investors have also recently modified their holdings of the company. CBIZ Investment Advisory Services LLC increased its stake in Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after acquiring an additional 150 shares during the last quarter. Maseco LLP purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $27,000. Global Wealth Strategies & Associates boosted its holdings in Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after purchasing an additional 300 shares during the last quarter. Grove Bank & Trust lifted its holdings in Colgate-Palmolive by 182.6% during the 4th quarter. Grove Bank & Trust now owns 407 shares of the company’s stock worth $32,000 after buying an additional 263 shares during the last quarter. Finally, Camelot Portfolios LLC bought a new position in Colgate-Palmolive during the 4th quarter worth approximately $32,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $88.61 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The stock has a market capitalization of $70.91 billion, a price-to-earnings ratio of 34.48, a PEG ratio of 4.60 and a beta of 0.33. The stock’s fifty day simple moving average is $86.49 and its 200 day simple moving average is $85.93. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 EPS. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were issued a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is presently 82.49%.

Analyst Upgrades and Downgrades

CL has been the topic of several recent analyst reports. Bank of America cut their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a research note on Friday, April 10th. Piper Sandler cut their target price on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Barclays boosted their price objective on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. UBS Group boosted their price objective on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 8th. Twelve investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.